Envoy Medical, Inc.(COCH)

Medical - Devices · White Bear Lake, MN

$0.65+0.00 (+0.23%)

Delayed quote: Oct 6, 2026, 3:10 PM EDT

Price/FCF Ratio: N/A

Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.

The Price/FCF ratio is N/A as of 2026-10-06T19:21:19.548Z.

Stored calculation inputs

Calculation as of: 2026-10-06T19:21:19.548Z.

Quote observation: 2026-10-06T19:10:08.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 50,369,473
TTM free cash flow · period ending 2026-06-30: -21,711,000

FMP input reference: fc92921354a3baefe39f76a6e19d16813aeb2294e32cc7e27fab112852b36d76

P/E Ratio|FCF Growth|Operating Margin|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

COCH Price/FCF Ratio Metrics

PRICE/FCF RATIO

N/A

COCH Competitors' Price/FCF Ratio

COCH

Envoy Medical, Inc.

Current

Market Cap

$50.37M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

DWTX

Dogwood Therapeutics, Inc.

vs COCH

Market Cap

$50.44M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

TENX

Tenax Therapeutics, Inc.

vs COCH

Market Cap

$50.80M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CLNN

Clene Inc.

vs COCH

Market Cap

$50.86M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ELOX

Eloxx Pharmaceuticals, Inc.

vs COCH

Market Cap

$51.03M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

INMB

INmune Bio, Inc.

vs COCH

Market Cap

$49.58M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

APLM

Apollomics, Inc.

vs COCH

Market Cap

$49.50M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

POCI

Precision Optics Corporation, Inc.

vs COCH

Market Cap

$49.36M

Price/FCF Ratio

N/A

TTM Avg

99.30

3Y Avg

99.30

5Y Avg

93.30

EXOZ

eXoZymes, Inc.

vs COCH

Market Cap

$51.51M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

TELA

TELA Bio, Inc.

vs COCH

Market Cap

$48.77M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PRICE/FCF RATIO	TTM	3Y	5Y
Envoy Medical, Inc. (COCH)	$50.37M	N/A	N/A	N/A	N/A
Dogwood Therapeutics, Inc. (DWTX)vs ›	$50.44M	N/A	N/A	N/A	N/A
Tenax Therapeutics, Inc. (TENX)vs ›	$50.80M	N/A	N/A	N/A	N/A
Clene Inc. (CLNN)vs ›	$50.86M	N/A	N/A	N/A	N/A
Eloxx Pharmaceuticals, Inc. (ELOX)vs ›	$51.03M	N/A	N/A	N/A	N/A
INmune Bio, Inc. (INMB)vs ›	$49.58M	N/A	N/A	N/A	N/A
Apollomics, Inc. (APLM)vs ›	$49.50M	N/A	N/A	N/A	N/A
Precision Optics Corporation, Inc. (POCI)vs ›	$49.36M	N/A	99.30	99.30	93.30
eXoZymes, Inc. (EXOZ)vs ›	$51.51M	N/A	N/A	N/A	N/A
TELA Bio, Inc. (TELA)vs ›	$48.77M	N/A	N/A	N/A	N/A

Free Cash Flow Valuation

P/FCF Ratio

N/A

FCF Yield

N/A

Price/FCF Ratio Formula & Definition

P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Price/FCF Ratio: N/A

COCH Price/FCF Ratio Metrics

COCH Competitors' Price/FCF Ratio

Free Cash Flow Valuation

Price/FCF Ratio Formula & Definition

Related Metrics